Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by Jonnyboy85on Nov 20, 2020 8:20pm
134 Views
Post# 31945853

RE:RE:RE:RE:Warrant revaluation

RE:RE:RE:RE:Warrant revaluationYa it's just more of the short game, trading games, basher games, they're only doing it because they want in at lower prices or think they can get a few more penny flips in before a run so they'll accumulate more before it happens. The reality is everyone, bashers, pumpers, longs, everyone is here because of the long term positive direction we're heading in. We all see the same partnerships, the same opportunities, hiring growth, now revenue growth and building blocks. They just all go about how they treat it differently and we all definitely disagree on that part. But I bet if you asked brad or bucky, they'd think I'm nuts for not day trading, and I think they're nuts for running the risk of being out when the big runs starts so I only buy. We all agree on the direction, we just all act on it differently. It's all a matter of perspective.
RelevantStock wrote:
Thanks Jonny well this is encouraging, thanks for the explanation. (6M) is quite heavy though in the report, I am having a hard time to figure out how this ER would be a good news with such a heavy loss. Aristotle also is scheduled early 2021 now, no more in 2020 but that was predictable lol.


<< Previous
Bullboard Posts
Next >>

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse